glp 1 for fatty liver GLP-1 Receptor Agonists in Non-Alcoholic Disease: Current Evidence and Future Perspectives Efficacy and safety of anti-obesity

Pfizer has said it expects pills to eventually capture about a third of the obesity drug market, which is predicted to grow to about $130 billion by the end of the decade.

Clinical trials of FDA-approved tirzepatide products have shown weight-related effects in some participants when used alongside diet and lifestyle changes

Black Friday Starts NOW

Semaglutide reduces appetite and changes how your body processes food, making protein intake critical for maintaining lean muscle during weight loss

This unique postbiotic combination increases butyrate, a short-chain fatty acid that directly stimulates GLP-1 receptors and helps extend feelings of fullness and improve metabolic control